Abstract
Introduction: #Natural killer (NK) cells are central components
of the #innate immunity. They have ability to kill a wide range of
cancer cells and are a promising tool for both autologous and allogeneic
immune enhancement therapy in cancer treatment. Actually, NK cells can
be derived from multiple sources such as: peripheral blood, cord
blood... Among these, cord blood (CB) is known as an ideal for NK cells
expansion because it occupies a higher percentage of NK cells compare to
the peripheral blood and is a rich source of #hematopoietic stem cell as
well as progenitor immune cells. The objectives of this study were to
invent a reasonable approach for expanding a relevant number of NK cells
from human cord blood to clinical application. Methods: At the initial
step, cord blood was collected from the patients and then the
mononuclear cells were obtained by #density centrifugation with Ficoll. After that, these cells were cultured in 2 stages: stimulation and
expansion with inactivated #autologous plasma and BINKIT expansion kit
contains several kinds of growth factors which are specified for NK
cells. The immunophenotype of NK cells was analyzed every 2 days through
%CD56+CD3- by Flow cytometry technique. The ex-vivo activation and
expansion of NK cells was performed in GMP grade -clean room for about 3
weeks.
For more articles on BJSTR Journal please click on https://biomedres.us/
For more Biomedical Imaging Articles on BJSTR
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.